跳至主要内容
临床试验/NCT07659886
NCT07659886尚未招募3 期

Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures

Atlantic Health System1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年6月10日最近更新:
干预措施

试验速览

阶段
3 期
状态
尚未招募
入组人数
100
试验地点
1

研究概览

简要总结

To evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to definitive surgical intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants aged 18 years or older presenting to the Emergency Department with Gustilo-Anderson Type I, II, or III open fractures.

排除标准

  • Known allergy to vancomycin
  • Ballistic open fractures
  • Pregnancy
  • Currently breastfeeding
  • Age younger than 18 years.

研究组 & 干预措施

Emergency Department Vancomycin Powder

Experimental

Patients receive 1 gram topical vancomycin powder applied to the open fracture wound in the Emergency Department in addition to standard open fracture management.

干预措施: Vancomycin (VAN) treatment (Drug)

Standard Open Fracture Care

Active Comparator

Patients receive standard open fracture management without Emergency Department (ED) vancomycin powder.

干预措施: Standard Open Fracture Care (Other)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristen De Wilde

Resident physician

Atlantic Health System

研究点 (1)

Loading locations...

相似试验